The PE Ratio as of December 2024 (TTM) for ImmuCell Corporation (ICCC) is -9.41

According to ImmuCell Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -9.41. This represents a change of 0.63% compared to the average of -9.35 of the last 4 quarters.

ImmuCell Corporation (ICCC) Historical PE Ratio (quarterly & annually)

How has ICCC PE Ratio performed in the past?

The mean historical PE Ratio of ImmuCell Corporation over the last ten years is -116.88. The current -9.41 PE Ratio has changed 705.12% with respect to the historical average. Over the past ten years (40 quarters), ICCC's PE Ratio was at its highest in in the September 2016 quarter at 231.80. The PE Ratio was at its lowest in in the June 2016 quarter at -787.39.

ImmuCell Corporation (ICCC) PE Ratio by Quarter and Year

Discovering the peaks and valleys of ImmuCell Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ImmuCell Corporation (ICCC) Average PE Ratio

How has ICCC PE Ratio performed in the past?

The current PE Ratio of ImmuCell Corporation (ICCC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

ImmuCell Corporation (ICCC) PE Ratio vs. Peers

How is ICCC’s PE Ratio compared to its peers?

ImmuCell Corporation’s PE Ratio is less than Transgene SA (-1.81), less than Alpha Cognition Inc. (-2.34), greater than Fennec Pharmaceuticals Inc. (-140.49), less than Lipella Pharmaceuticals Inc. (-0.00), less than Eliem Therapeutics, Inc. (0), less than Cyteir Therapeutics, Inc. (-9.12), less than Anebulo Pharmaceuticals, Inc. (-5.30), less than HCW Biologics Inc. (-0.40), less than MediciNova, Inc. (-0.04), less than AgeX Therapeutics, Inc. (-1.48), less than Lineage Cell Therapeutics, Inc. (-5.04), less than Cadrenal Therapeutics, Inc. Common Stock (-2.14), less than Oxford Nanopore Technologies plc (-5.79), less than Rezolute, Inc. (-4.44), greater than XOMA Corporation (-10.60), less than Protagenic Therapeutics, Inc. (-0.39), less than Tempest Therapeutics, Inc. (-0.62),

Build a custom stock screener for ImmuCell Corporation (ICCC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ImmuCell Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ImmuCell Corporation (ICCC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ImmuCell Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.